Market revenue in 2023 | USD 1,875.6 million |
Market revenue in 2030 | USD 3,569.7 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Aneroid blood pressure monitors |
Fastest growing segment | Digital Blood Pressure Monitors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Aneroid Blood Pressure Monitors, Digital Blood Pressure Monitors, Ambulatory Blood Pressure Monitors, Blood Pressure Transducers, Instrument & Accessories |
Key market players worldwide | OMRON Corp, A&D Medical, SunTech Medical, American Diagnostic Sciences, Nokia Oyj, Briggs Healthcare Corp., GE HealthCare Technologies Inc Common Stock, Microlife Corp, Procter & Gamble Co, Spacelabs Healthcare, Koninklijke Philips NV, Hill-Rom, B. Braun, CONTEC, Kaz, Inc., Rossmax International, Biobeat |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood pressure monitoring devices market will help companies and investors design strategic landscapes.
Aneroid blood pressure monitors was the largest segment with a revenue share of 33.57% in 2023. Horizon Databook has segmented the U.S. blood pressure monitoring devices market based on aneroid blood pressure monitors, digital blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, instrument & accessories covering the revenue growth of each sub-segment from 2018 to 2030.
According to CDC, nearly 108 million adults in the country had hypertension in 2018, and high BP was the primary cause of deaths for around 494,873 U.S. residents in the same year. Moreover, High BP costs the country nearly USD 131 billion every year.
The high prevalence of high BP, coupled with high expenditure to manage the condition, is anticipated to drive market growth in the country. In 2019, the FDA granted approval to Biobeat—an Israel-based company—for its wearable and cuff less BP monitor.
This device can be employed for BP monitoring in not only hospitals and clinics but also at home, enabling physicians continuously monitor patients. Availability of such advanced BP monitoring systems in the U.S. market is expected to favor market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. blood pressure monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. blood pressure monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account